PPT-Measles and rubella investment cases: Stakeholder analysis

Dr Kimberly M Thompson 11 th Annual Measles and Rubella Partners Meeting September 19 2012 Acknowledgments World Health Organization WHO Contract PO 200470477 APW Radboud Duintjer . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . --Who We Are--. Stephen Cochi, . MD, MPH. Global . Immunization Division. Centers . for . Disease Control & Prevention. What is the Measles & Rubella Initiative? . Anne Ray Charitable Trust. Panel 01502. Vicki Stambos. The 13. th. Global Measles and Rubella Laboratory Network Meeting, Geneva, Switzerland, 29. th. June to 1. st. July 2015. Vicki Stambos. Accelerating Progress Towards Measles and Rubella Control and Elimination Meeting. . Accelerating Progress towards Measles/Rubella Control and Elimination Goals Meeting. Geneva, Switzerland. June 19, 2016. Lance Rodewald. WHO China Country Office. Measles and Rubella Vaccination Schedule. --Who We Are--. Stephen Cochi, . MD, MPH. Global . Immunization Division. Centers . for . Disease Control & Prevention. What is the Measles & Rubella Initiative? . Anne Ray Charitable Trust. . Mona Aryal. HOD, Health Service Department. Nepal Red Cross Society. National Headquarter. . Nepal Red Cross Society’s Initiative. Vision: . to . provide immediate relief to human suffering and reduce vulnerability, under the Fundamental Principles of the Red Cross, . M&RI Partners’ Meeting. Michael F Thomas, . Director Vaccine Implementation. September 2017, Washington DC. Page: . 1. Reach every child. . Measles and Rubella support in Gavi countries by end of 2016. Dr. Kimberly M. Thompson. Kid Risk, Inc., www.kidrisk.org. Topics. Context. I. ntegrated dynamic disease and economic . modeling. Discussion. http://www.wpro.who.int/vietnam/topics/immunization/measles_rubella/measles_rubella_big.png?ua=1. Measles and Rubella Annual Partners Meeting, September 15-16 2015. Background. The MRI FRR is developed by the M&RI FRR/RMAWG. Country population data is drawn from UNDP estimates. Vaccine type and timing of SIAs is from countries . Hotel Royal, Geneva, Switzerland, 21-23 June 2016. Paul Rota,. Measles, Mumps, Rubella, Herpesviruses Laboratory Branch, CDC . par1@cdc.gov. . National Center for Immunization & Respiratory Diseases. ALL students are REQUIRED to provide proof of immunity to measles, mumps, and rubella (“MMR”). Before students may enroll in classes, NAU requires documentation of ONE of the following: • Tw Accelerating Progress Towards Measles and Rubella Elimination. 23 June 2016. Geneva. , Switzerland. Minal K. Patel WHO HQ IVB/EPI. Background. Growing demand for periodic cross-sectional surveys to identify population immunity gaps. Opening Comments & Perspectives. Dr. Suresh Jadhav. Executive Director. Serum Institute of India Pvt. Ltd.,. ssj@seruminstitute.com. . We, at Serum Institute of India Pvt. Ltd., feel proud of being a partner to PAHO / WHO in achieving what is designated to be a historical achievement in eradication of Measles & Rubella diseases from the Americas.. .. Education Department.. Kolkata. . Measles . - . An acute viral infection spread via respiratory secretions or aerosols. leading causes of death . among young children . even though a safe and cost-effective vaccine is available.